Anees Bahji Publications

2024

• Bahji A. (2024). Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review. J Clin Med. 9;13(4):999.
• Bahji A, Boonmak P, Koller M, Milani C, Sutherland C, Horgan S, Chen SP, Patten S, Stuart H. (2024). Associations between Gender Expression, Protective Coping Strategies, Alcohol Saliency, and High-Risk Alcohol Use in Post-Secondary Students at Two Canadian Universities. Int J Environ Res Public Health. 21(1):107.

2023

• Bahji A, Lunsky I, Gutierrez G, Vazquez G. (2023). Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. J Psychoactive Drugs. 15:1-16.
• Babor T, Tsiboukli A, Hellman M, Bahji A. (2023). Ways to get a more balanced gender representation in addiction journals’ management and workforce. Nordisk Alkohol Nark. 40(6):560-567.
• Bahji A. (2023). Guilty until proven innocent. Can Med Educ J. 14(5):149.
• Bahji A, Danilewitz M, Crockford D, Delva N, Rusak B. (2023). Assessing research competency development in Canadian psychiatry residency programs: A systematic review and future directions. SAGE Open Med. 11:20503121231216846.
• Bahji A, Socias ME, Bach P, Milloy MJ. (2023). Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective. Cannabis Cannabinoid Res. 8(5):699-702.
• Bahji A, Danilewitz M, Crockford D. (2023). Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders. Brain Sci. 13(10):1416.
• Bahji A, Danilewitz M, George TP, Dhaliwal A, Crockford DN. (2023). Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited. CMAJ. 195(39):E1354.
• Bahji A, Hathaway J, Adams D, Crockford D, Edelman EJ, Stein MD, Patten SB. (2023). Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada. Addiction. 2023 Sep 27.
• Bahji A, Bastien G, Bach P, Choi J, Le Foll B, Lim R, Jutras-Aswad D, Socias ME. (2023). The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial. Can J Psychiatry. 2023 Sep 12:7067437231194385.
• Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C Jr, Vazquez G, Loo C. (2023). Ketamine for the treatment of major depression: a systematic review and meta-analysis. EClinicalMedicine. 62:102127.
• Bahji A, Gordon KS, Crystal S, Satre DD, Wiliams EC, Edelman EJ, Justice AC. (2023). Factors Associated with Bothersome Symptoms in Individuals With and Without HIV Who Report Alcohol Use. AIDS Behav. 27(7):2455-2462.
• Bahji A, Dhaliwal A, Sachdev A, Danilewitz M, Lamba W, George TP, Chopra N, Crockford D. (2023). The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment. Can J Psychiatry. 68(3):208-209.
• Bahji A, Acion L, Laslett AM, Adinoff B. (2023). Exclusion of the non-English-speaking world from the scientific literature: Recommendations for change for addiction journals and publishers. Nordisk Alkohol Nark. 40(1):6-13.
• Rafizadeh R, Danilewitz M, Bousman CA, Mathew N, White RF, Bahji A, Honer WG, Schütz CG. (2023). Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis. J Psychopharmacol. 37(2):135-143.

2022

• Bahji A, Danilewitz M, Maser B, Guerin E, Frank E. (2022). Association between substance use and professional outcomes among medical students: Findings from a Canadian cross-sectional survey. Can J Addict. 13(4):32-43.
• De Aquino JP, Bahji A, Gómez O, Sofuoglu M. (2022). Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies. Drug Alcohol Depend. 241:109702.
• De Aquino JP, Bahji A, D’Souza DC. (2022). Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again? Cannabis Cannabinoid Res. 7(6):898-900.
• Bahji A, Bach P, Danilewitz M, Crockford D, Devoe DJ, El-Guebaly N, Saitz R. (2022). Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis. J Addict Med. 16(6):630-638.
• Bahji A, Milloy MJ, Bach P, Sociás ME. (2022). Challenges and opportunities for further research involving the cannabis-to-opioid use transition. Addiction. 117(10):2752-2754.
• Bahji A, Bach P, Danilewitz M, Crockford D, El-Guebaly N, Devoe DJ, Saitz R. (2022). Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis. Addiction. 117(10):2591-2601.
• Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, Chowdhury M, Seitz DP. (2022). Correction: Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022 Sep 12;22(1):742.
• Kleinman RA, Brothers TD, Danilewitz M, Bahji A. (2022). Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model. J Addict Med. 16(5):499-504.
• Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, Chowdhury M, Seitz DP. (2022). Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis. BMC Geriatr. 22(1):601.
• Bahji A, Crockford D, El-Guebaly N. (2022). Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review. J Stud Alcohol Drugs. 83(4):470-479.
• Bahji A, Crockford D, El-Guebaly N. (2022). Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review. J Stud Alcohol Drugs. 83(4):461-469.
• Bahji A, Li Y, Vickers-Smith R, Crystal S, Kerns RD, Gordon KS, Macmadu A, Skanderson M, So-Armah K, Sung ML, Bhondoekhan F, Marshall BDL, Edelman EJ. (2022).Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study. Int J Environ Res Public Health. 19(9):5649.
• Bahji A, Breward N, Duff W, Absher N, Patten SB, Alcorn J, Mousseau DD. (2022). Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review. J Cannabis Res. 2022 Mar 14;4(1):11.
• Brothers TD, Bahji A. (2022). Patients With Infective Endocarditis Deserve Evidence-based Addiction Treatment. Ann Thorac Surg. 113(3):1048-1049.
• Bahji A, Meyyappan AC, Hawken ER, Tibbo PG. (2022). Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. Int J Drug Policy. 2021 Nov;97:103295.
• Devoe DJ, Anderson A, Bahji A, Singh M, Patten SB, Soumbasis A, Ramirez Pineda A, Flanagan J, Richardson C, Lange T, Dimitropoulos G, Paslakis G. (2022). The Prevalence of Impulse Control Disorders and Behavioral Addictions in Eating Disorders: A Systematic Review and Meta-Analysis. Front Psychiatry. 2022 Jan 6;12:724034.

2021

• Bahji A, Meyyappan AC, Hawken ER, Tibbo PG. (2021). Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. Int J Drug Policy. 97:103295.
• Bahji A, Danilewitz M, Guerin E, Maser B, Frank E. (2021). Prevalence of and Factors Associated With Substance Use Among Canadian Medical Students. JAMA Netw Open. 4(11):e2133994.
• Bahji A, Smith J, Danilewitz M, Crockford D, El-Guebaly N, Stuart H. (2021). Towards competency-based medical education in addictions psychiatry: a systematic review. Can Med Educ J. 12(3):126-141.
• Bahji A. (2021). Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal. Can J Psychiatry. 66(6):586-587.
• Bahji, A, Brietzke, E, Soares, C, Stuart, H. (2021). Recent Advances in Biomarkers of Addiction: A Narrative Review. The Canadian Journal of Addiction. 12(1):6-12.

2020

• Bahji A. (2020). Alcohol-related psychiatric presentations at a university-affiliated emergency department: a descriptive prevalence study. Canadian Journal of Addiction. 11(4):17-22.
• Mauer-Vakil D, Bahji A. (2020). The addictive nature of compulsive sexual behaviors and problematic pornography consumption: A review. Canadian Journal of Addiction. 11(3):42-51.
• Bahji A, Reshetukha T, Newman A, Good L, Gupta P, Haffey S, Gingrich T, Hicks M, Zuoros I, Reid R, Majere R, Fraser S. (2020). The Substance Treatment and Recovery Team (START): Measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital. Gen Hosp Psychiatry. 67:160-161.
• Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Cannabinoids for the neuropsychiatric symptoms of dementia: a systematic review and meta-analysis. Canadian Journal of Psychiatry. 65(6): 365-376.
• Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis. Journal of Psychiatric Research. 129:257-264.
• Bahji A, Danilewitz M, Crockford D. (2020). Response to Canadian Psychiatric Association. Opioid Use Disorder Position Statement: More than Just Collaborators in Care. Canadian Journal of Psychiatry. 59:37-50.
• Danilewitz M, Bahji A. (2020). Unexpected turn of events: graduating in the COVID-19 era. Canadian Journal of Medical Education.
• Bahji A, Cheng B, Gray S, Stuart H. (2020). Mortality among people with opioid use disorder: a systematic review and meta-analysis. American Journal of Addiction Medicine. 14(4):e118-e132.
• Bahji A, Reshetukha T, Newman A, Good L, Gupta P, Haffey S, Gingrich T, Hicks M, Zuoros I, Reid R, Majere R, Fraser S. (2020). The Substance Treatment and Recovery Team (START): measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital. General Hospital Psychiatry. S0163-8343(20)30070-0.
• Bahji A, Yanagawa B, Lamba W. (2020). Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review. Canadian Journal of Addiction. 11(2): 13- 23.
• Bahji A. (2020). Methamphetamine-Related Emergency Department Visits Requiring Psychiatric Admission: A Retrospective Cohort Study. International Journal of Mental Health and Addiction. 18(1): 1-10.
• Bahji A. (2020). Incidence and correlates of opioid-related psychiatric emergency care: a retrospective, multi-year cohort study. Journal of Opioid Management. 16(3): 223-226.
• Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz D. (2020). Prevalence of cannabis withdrawal among regular or dependent users of cannabinoids: a systematic review and meta-analysis. Journal of the American Medical Association—Open Network. 3(4): 3095.
• Bahji A. (2020). Commentary on Hayes et al. (2019): The harms of opioid dose escalation in the management of chronic non-cancer pain. Addiction. 115(6): 1113-1114.
• Bahji A, Carlone D, Altomare J. (2020). Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis. Addiction. 115(8): 1413-1425.

2019

• Bahji A. (2019). Incidence and correlates of cannabinoid-related psychiatric emergency care: a retrospective, multi-year cohort study. Canadian Journal of Addiction. 11 (1), 14-18.
• Bahji A, Stephenson C. (2019). International perspectives on the implications of cannabis legalization: A systematic review & thematic analysis. International Journal of Environmental Research and Public Health. 16(17): 3095.
• Bahji A, Cheng B, Gray S, Stuart H. (2019). Reduction in mortality risk with opioid agonist therapy: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 140(4): 313-339.
• Bahji A, Forsyth A, Hawken E, Groll D. (2019). Efficacy of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder: a systematic review & meta-analysis. Progress in Neuropsychopharmacology and Biological Psychiatry. 19(96): 109735.
• Bahji A, Camire D. (2019). The Local Response to the Canadian Opioid Epidemic in the Kingston, Frontenac, and Lennox & Addington communities. Health Promotion and Chronic Disease Prevention in Canada. 39(12): 333-336.
• Bahji A. (2019). Commentary on Stockings et al.  The global amphetamine epidemic-a rising tide of mortality. Addiction. 114(10): 1751-1752.
• Bahji A. (2019). Effectiveness of Naltrexone for Opioid Use Disorder among Inmates: A Systematic Review and Meta-Analysis. Journal of Advancement in Criminal Justice. 2:73-92.
• Bahji A, Bajaj N. (2019). The value of hospitalization in the opioid epidemic: a scoping review. Canadian Journal of Addiction. 10(2): 6-17.
• Elbatarny M, Bahji A, Bisleri G, Hamilton A. (2019). Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies. General Hospital Psychiatry. 57: 44-49.
• Bahji A, Mazhar MN, Hudson C, Nadkarni P, McNeil B, Hawken E. (2019). Prevalence of substance use comorbidity in individuals with eating disorders: A systematic review & meta-analysis. Psychiatry Research. 273: 58-66.
• Bahji A, Lusty E, Majere RA, Newman A, Reshetukha T, Carvalhal A. (2019). Piloting an Addictions Medicine Consultation Team in Kingston, Ontario, Canada: Results of an Inpatient Needs Assessment. Canadian Journal of Addiction. 10(1):29–32.
• Bahji A. (2019). An Epidemic of Incompetence: A Critical Review of Addictions Curriculum in Canadian Residency. MedEd Publish. 8(1).

2018

• Bahji A, Bajaj N. (2018). Opioids on trial: A systematic review of interventions for the treatment and prevention of opioid overdose. Canadian Journal of Addiction. 9(1): 26-33.
• Bahji A, Hargreaves T, Finch S. (2018). Assessing the Utility of Drug Screening in the Emergency: A Short Report. British Medical Journal Open Quality. 7: e000414.
• Yanagawa B, Bahji A, Lamba W, Tan D, Cheema A, Syed I, Verma S. (2018). Endocarditis in the Setting of Injection Drug Use: Multidisciplinary Management. Current Opinions in Cardiology. 33(2): 140-147.
• Bahji A, Camire D. (2018). Letter to the Editor: A Case for Opioid Education and Training for Medical Students, Residents, and Allied Health Staff: Response To “Educational Intervention for Physicians to Address the Risk of Opioid Abuse.” Journal of Opioid Management. 14(3): 157.
• Bahji A, Scimeca M, Hurley B, Penders T, Stanciu C. (2018). A Case of Synthetic Cannabinoid Abuse: Summary of Case Conference from American Academy of Addictions Psychiatry 2017 Annual Meeting. American Journal on Addictions. 27: 265-272.

2017 and earlier

• Bahji A, Bajaj N. (2017). Historical, Clinical, and Public Health Considerations of ‘Bath Salt’ Use: An Emerging Drug of Abuse. The Canadian Journal of Addiction. 8(1): 6-11.
• Bahji A, Mazhar MN. (2016). Treatment of Cannabis Dependence with Synthetic Cannabinoids: A Systematic Review. Canadian Journal of Addictions. 7(4):8-13.
• Bahji A, Wood E, Ahamad K, Dong H, DeBeck K, Milloy MJ, Kerr T, Hayashi K. (2015). Increasing awareness about HIV prevention among young people who initiated injection drug use in a Canadian setting, 1988-2014. The International Journal of Drug Policy. 26(12): 1258-1264.